OBJECTIVE: To examine the relationships between the distribution and composition of subfractions of very low density (VLDL), low density (LDL) and high density (HDL) lipoproteins and central fat deposition as measured by the waist-to-hip ratio (WHR). DESIGN: Participants (n 62, 44 women and 18 men; body mass index (BMI) ! 25.0) were recruited from those consecutively attending the outpatient obesity clinic at the University Hospital, Geneva. MEASUREMENTS: Lipoprotein subfractions were isolated from fasting blood samples by cumulative¯otation or density gradient ultracentrifugation. Concentration and composition were analysed as a function of obesity indices. RESULTS: There were signi®cant correlations between the WHR and the pro®les of the three major lipoprotein subclasses. Central obesity was associated with larger VLDL, small, dense LDL and lower levels of HDL-2 independently of other indices of obesity and plasma triglycerides. Central obesity was also signi®cantly and independently associated with compositional anomalies, speci®cally an increased free cholesterol content of VLDL and LDL. CONCLUSIONS: Central body fat was associated with modi®cations of an atherogenic nature to lipoprotein distribution and composition. The data are consistent with an impact of body fat distribution on cardiovascular disease (CVD) via the agency of modi®ed lipoprotein metabolism independently of raised triglycerides.
Introduction
Obesity has a negative impact on health, being associated with cardiovascular disease, hypertension and diabetes. 1, 2 Numerous studies have helped re®ne this concept by demonstrating that a crucial factor is body fat distribution. 3±5 The pathological sequelae, notably as regards cardiovascular disease (CVD), are primarily a consequence of central or visceral fat accumulation. 5, 6 The mechanisms linking obesity to the increased risk of cardio vascular disease (CVD) are not clear. Anomalies of blood lipidalipoprotein metabolism are an obvious consideration and obesity clearly has a negative impact on lipid risk factors, particularly triglycerides and high density lipoprotein (HDL) cholesterol. 5, 7 In recent years, interest in the lipoprotein ®eld has focused on the cardiovascular risk consequences of qualitative modi®cations, as re¯ected in compositional and distributional changes to lipoproteins. A limited number of studies have considered such modi®cations in obesity, and these have reported a relationship between visceral fat accumulation and pathological changes to the lipoprotein pro®le, particularly at the low density lipoprotein (LDL) level. 8±12 However, these conclusions are subject to caution as the possible confounding effect of triglycerides, which are positively correlated with visceral fat accumulation, has not been taken into account in the majority of studies. Triglycerides have the strongest impact on the lipoprotein pro®le. 13, 14 To our knowledge, only two studies, focusing on the LDL pro®le, have adjusted for triglycerides; in one 15 the presence of small, dense LDL was independently related to visceral fat accumulation, whilst the association was no longer signi®cant when corrected for triglycerides in a more recent study. 16 It thus remains unclear whether central obesity could in¯u-ence lipoprotein metabolism directly or via the agency of raised triglyceride levels. In the context of de®ning a potential impact of visceral fat accumulation on the risk of CVD via modi®ed lipoprotein metabolism, the aims of the present study were two-fold: a) to examine the relationship between central obesity (de®ned by the waist-to-hip ratio (WHR)) and i) the lipoprotein subfraction distribution, ii) lipoprotein subfraction composition; b) to determine if any relationships were independent of other parameters, notably triglycerides. ment of the Polyclinic of Medicine at the University Hospital, Geneva. All were of Caucasian origin. Exclusion criteria included treatment for dyslipidaemia and diabetes (fasting blood glucose level b 7.8mmolal). The WHR was determined by standard procedures. 17 Waist circumference was taken at the level of the umbilicus and hip circumference was measured at the widest part of the gluteal area. The percent body fat was estimated by the measurement of 4 skinfolds (triceps, biceps, subscapular and suprailiac 18 ) and by the bioelectrical impedance technique described by Lukaski 19 and Schutz and Bracco. 20 The latter technique has been validated in obese subjects with, however, an overestimation of lean tissues in patients whose excess weight is b 48%. 21, 22 The percentage fat was taken as the mean of these two measurements which were in very good agreement.
A blood sample was obtained in Ethylenediamine tetraacetic acid (EDTA conventionally used) after an overnight fast and centrifuged (3000 g, 30 min) to obtain plasma. Total HDL-cholesterol was determined after precipitation of lower density lipoproteins with phosphotungstate. 23 Subfractions of very low density lipoproteins (VLDL) and LDL were isolated by cumulative¯otation ultracentrifugation, as described previously. 24, 25 HDL subfractions 2 and 3 were obtained by density gradient ultracentrifugation. 26, 27 Lipids (triglycerides, phospholipids, free and esteri®ed cholesterol) in lipoprotein subfractions and whole plasma were quanti®ed using commercially available enzymatic procedures, as described. 23, 25 The protein content of the isolated subfractions was determined by Lowry assay. 28 The plasma concentrations of the subfractions were calculated as the sum of the concentrations of the individual lipid and total protein components. 23, 25 The study was performed in accordance with the ethical requirements of the medical faculty, University of Geneva.
Statistical analyses
Values are expressed as means AE s.d. Log transformation of plasma concentrations of triglycerides and VLDL subfractions 1, 2 and 3 were performed prior to analyses. The Pearson correlation coef®cient was used to test associations between pairs of variables where signi®cance was determined by the least squares method. Multivariate analysis was used, calculating partial coef®cients, to determine independent associations between WHR and selected variables. Forward stepwise logistic regression analysis was performed to identify models that best described variations in plasma concentrations of lipoprotein subfractions. Statistical analyses were performed using the JMP statistical package (SAS Institute Inc, Cary, USA). Table 1 gives the anthropometric and clinical characteristics of the group of obese subjects. Mean cholesterol and triglyceride concentrations were mildly elevated, but within clinically acceptable limits. HDL-cholesterol was also within acceptable limits, although towards the lower end of the normal distribution spectrum. Within the VLDL density range the smallest subfraction (VLDL-3) was present in the highest concentration, whereas LDL-2 dominated the LDL spectrum. Larger, less dense LDL-1 (which is equivalent to intermediate density lipoproteins) was present in higher concentrations than LDL-3 (small, dense LDL), probably re¯ecting the greater proportion of women in the group under study. The smaller, denser subfraction of HDL (HDL-3) was predominant within this density spectrum.
Results
The WHR was positively correlated with plasma triglycerides (r 0.28, P 0.032) and cholesterol (r 0.28, P 0.033) and negatively correlated with HDL-cholesterol (r 70.31, P 0.017).
Lipoprotein subfraction concentrations
Univariate correlations between WHR and plasma concentrations of the subfractions are noted in Table  2 . Signi®cant, positive correlations were observed for VLDL-1, VLDL-2 and LDL-3, whilst correlations were of borderline signi®cance with VLDL-3 (P 0.08). Signi®cant, negative correlations were observed between WHR and the HDL subfractions. When adjusted for triglycerides (Table 2) correlations remained signi®cant for VLDL-2, LDL-3 and the HDL subfractions. In contrast, WHR was no longer signi®cantly associated with VLDL-1 and borderline signi®cance with VLDL-3 was eliminated. When other indices of obesity and gender were taken into account, signi®cant correlations were maintained with VLDL-2, LDL-3 and the HDL subfractions (Table 2) . Small, dense LDL (here LDL-3) and large HDL (HDL-2) are considered to be of particular relevance to mechanisms involved in cardiovascular pathology.
Stepwise logistic regression analysis was performed to determine which of the available data variables contributed to variations in their plasma concentrations. As shown in Table 3 , plasma concentrations of LDL-3 were independently associated with WHR, triglycerides (both positive) and percent body fat (negative). These parameters accounted for 42% (adjusted value) of the variations in the plasma levels of this subfraction. BMI was notably implicated in the model de®n-ing HDL-2 concentrations, together with WHR, percent body fat, triglycerides and plasma cholesterol. This model explained 33% of variations in concentrations of HDL-2.
Lipoprotein subfraction composition
When correlations between WHR and absolute concentrations of components of apo B-containing lipoproteins were analysed, signi®cant, positive correlations were observed for all components of VLDL-1, VLDL-2 and LDL-3 (results not shown). When adjusted for plasma triglyceride levels, associations remained signi®cant for all components of VLDL-2 (except for esteri®ed cholesterol, r 0.19, P b 0.10) and LDL-3 (aside from triglycerides r 0.23, P 0.08). WHR was no longer signi®cantly correlated with components of VLDL-1, with the exception of free cholesterol (univariate correlation r 0.39, P 0.003; adjusted for triglycerides r 0.30, P 0.02). The free cholesterol component of VLDL-3 was also signi®cantly associated with WHR in univariate analysis, but not after taking plasma triglyceride levels into consideration. All components of HDL-2 were signi®cantly and negatively correlated with WHR, even after adjusting for triglycerides. For HDL-3, signi®cant correlations between WHR and phospholipids and free cholesterol were noted for univariate analyses with the protein component being borderline. After adjusting for triglycerides, HDL-3 phospholipids and triglycerides were independently associated with WHR, whereas the correlation with free cholesterol was no longer signi®cant.
When the percent composition of the subfractions was analysed, a somewhat different picture emerged. Within the VLDL spectrum, WHR was signi®cantly and positively associated only with the free cholesterol component of VLDL-1 (r 0.32, P 0.014) and VLDL-2 (r 0.45, P 0.0004). These correlations were independent of plasma triglyceride levels (VLDL-1, r 0.32, P 0.017; VLDL-2, r 0.37, P 0.004). For LDL, signi®cant correlations were only observed with the components of LDL-2; a positive correlation with the percent protein (r 0.38, P 0.003) and negative correlations with phospholipids (r 70.38, P 0.003) and esteri®ed cholesterol (r 70.27, P 0.041). Within the HDL spectrum, the percent phospholipid and free cholesterol components of both subfractions were negatively correlated with WHR (respectively r 70.40, P 0.003; r 70.27, P 0.040 for HDL-2 and r 70.38, P 0.004; r 70.27, P 0.043 for HDL-3). (Table 4) . No correlations between the ratios of these lipids and WHR was observed for the other subfractions, with the exception of LDL-2, when adjusted for triglycerides (Table 4) . A similar analysis of the ratios of the core lipids (triglyceridesaesteri®ed cholesterol) revealed no relationship with the WHR for any subfraction.
Discussion
The present study furnishes novel observations concerning the relationship between central obesity and lipoprotein anomalies. Furthermore, it clari®es certain aspects of previous reports related to obesity and lipoproteins. Finally, the study consolidates the association between central obesity and lipoprotein modi®cations of an apparently atherogenic nature.
There is growing evidence that central obesity is one facet of the plurimetabolic syndrome or syndrome X. 6, 29 It implies caution when attempting to link any two factors within this cluster of metabolic anomalies. Lipoprotein distribution and composition are highly sensitive to plasma triglycerides, 13 whose impact is evident at low concentrations. 16, 30 It is therefore important to adjust for triglycerides when investigating ties between obesity and lipoproteins, especially as obesity is associated with increased concentrations of the lipid. A caveat to this statement is that triglycerides may be a component of the mechanism linking obesity to vascular disease and over-adjustment could mask physiologically relevant associations. This point is illustrated by the debate surrounding the independence of the association between triglycerides themselves and vascular disease. 31 Furthermore, it should be remembered that the present study employed the WHR. Although the most common means of de®ning fat distribution and a good correlate of deep, abdominal fat, 7,32 it does not give as precise a description of abdominal fat distribution as more sophisticated techniques. 7, 32 Nevertheless, within these limitations, the present and previous studies 15, 16 have shown that the corrections can re®ne our perception of the relationship between body fat distribution and lipoproteins.
Thus, the present study shows signi®cant relationships between WHR and large VLDL (1 2), as well as borderline signi®cance with VLDL-3 in univariate analysis. When adjusted for triglycerides, only VLDL-2 emerges as an independent correlate of WHR. An early study showed independent associations of these two VLDL fractions with WHR, but did not adjust for triglycerides. 8 A recent study reported that large VLDL was not a correlate of body fat distribution independent of triglycerides, but the report did not differentiate between VLDL-1 and 2. 16 Our results suggests that central obesity is associated with increased synthesis of larger (but not the largest) VLDL particles, independent of any rise in triglycerides. Whilst data based on correlations should be interpreted with caution, it should be noted that VLDL production is sensitive to plasma free fatty acid concentrations. 33 In addition, there are indications that modulation of plasma free fatty acid concentrations can affect VLDL size. 33, 34 The cardiovascular consequences of an increase in large VLDL is a topic of particular interest. Numerous studies have demonstrated their association with extensive, pro-atherogenic changes of LDL and HDL. 13, 35, 36 In addition there is evidence that large VLDL can themselves promote cholesterol accumulation by cells. 37 Modulation of the LDL pro®le, notably the presence of small, dense LDL particles, has attracted widespread attention because of the links with coronary heart disease. 38±40 Several studies have reported a positive association between central obesity and small LDL.
8±12 Few, however, have also taken triglycerides into account. We observed a positive relationship between WHR and LDL-3 which was independent of triglycerides and other variables. The results parallel those reported by Selby et al, 15 in a large group of female twins. In contrast, Tan et al 16 observed no signi®cant correlation between LDL-3 and central obesity when corrected for triglycerides. This study was restricted to normolipaemic subjects who appeared to be at best overweight, rather that obese. It has been suggested that obesity is necessary for the effects of central adiposity to manifest. 10 Terry et al 8 also observed a positive correlation between WHR and small LDL, but triglycerides were not taken into account. In the present study, adjustment for gender did not modify the association between WHR and small LDL, despite recent suggestions that there may be male-female differences in the relationship between central obesity and lipoprotein metabolism.
11 Small, dense LDL represent an important risk indicator for CVD, as has been convincingly demonstrated.
38±40 Their origins are unclear, although the lipolytic action of hepatic lipase on LDL enriched in triglycerides due to the activity of lipid transfer protein, has been implicated. 16, 41 What remains uncertain is the extent to which these lipoprotein particles may play an active role in the atherogenic process.
Numerous studies have demonstrated a negative relationship between obesity and the cholesterol component of HDL. In contrast, there is little data on the relationship between body fat distribution and total HDL subfraction concentrations. The present study demonstrates a negative relationship between WHR and both HDL subfractions, independent of triglycerides and other subfractions. This partially concords with studies by Terry et al 8 concerning HDL-2, although the latter did not correct for triglycerides and Walton et al, 42 where triglycerides were taken into account. They did not, however, report a correlation between WHR and HDL-3. Population differences may explain the discrepancies. Whilst WHR was independently associated with reduced HDL-2, stepwise regression analysis indicated that BMI would appear to have a greater, negative association with the subfraction. Given the well documented, cardio-protective in¯uence of HDL, reductions in its plasma concentrations would appear to place obese subjects at increased risk.
There were no major compositional changes to subfractions that were speci®cally attributable to central adiposity. However, there were modi®cations to the free cholesterol content, notably for large VLDL, which were independently associated with body fat distribution. This is an important and intriguing observation. Its importance lies in the hypothesis that an increased free cholesterol content of lipoproteins (relative to phospholipids) is an independent risk factor for coronary heart disease. 43 The mechanism by which this modi®cation could in¯uence the atherogenic process is not known. Speculation presently centres on the possibility that higher free cholesterol could decrease the¯uidity of the outer surface of lipoprotein subfractions thus in¯u-encing their participation in different metabolic processes (lipid exchange, lipolysis and receptor recognition). As regards the cause of higher free cholesterol, it would appear to indicate increased synthesis; this is interesting in that diabetes, one eventual consequence of obesity, is also associated with increased cholesterol synthesis. 44 Central obesity is now considered to be one facet of the plurimetabolic syndrome or syndrome X. 6, 29 It is thus important to ensure that associations between WHR and lipid parameters are independent of other metabolic factors implicated in this syndrome, notably triglycerides. Our study suggests this is the case and provides several novel observations concerning the relationships between central adiposity and lipid metabolism.
Although not proof of a causative role, the data are consistent with an impact of body fat distribution on CVD via the agency of modi®ed lipoprotein metabolism.
